# LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment

> **NCT05366504** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Institute for the Study of Urological Diseases, Greece** · enrollment: 60 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **COMBINATION_PRODUCT:** LiST + PRP intracorporeal injection
- **COMBINATION_PRODUCT:** LiST + Placebo(normal saline intracorporeal injection)

## Key facts

- **NCT ID:** NCT05366504
- **Lead sponsor:** Institute for the Study of Urological Diseases, Greece
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09
- **Primary completion:** 2023-12
- **Final completion:** 2024-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05366504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05366504, "LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05366504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*